|
|
|
|
||
Re: JPM - SGMO: ZFPs Point Towards a Potentially Disruptive Future ...Initiating at OW TP 22JPM's $22 price target… ~$4/share to HIV, ~$15/share for the robust pre-clinical pipeline and tech platform, plus ~$3/share in estimated YE15 cash yet so much angst here lately re this MB's propagated "missed HIV IND deadline" let's go back to trashing the insider selling… after selling $100M at $22.50, the continued insider selling (without a minimum price threshold > $18) is now overdone and excessive |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
67104 | Re: JPM - SGMO: ZFPs Point Towards a Potentially Disruptive Future ...Initiating at OW TP 22 | ROGI | 20 | 9/2/2014 9:55:33 PM |